An alternative hypoxia biomarker is pimonidazole, which needs to be injected 1–2 h before scarification of the tumor-bearing mice and has been regarded as more superior because of this exogenous use in contrast to the endogenously produced CAIX (37, 38). The gene discussed is CA9; the disease is neoplasm.